Skip to main content

Table 1 Demographic and clinical characteristics of study populations

From: Human rhinovirus infection causes different DNA methylation changes in nasal epithelial cells from healthy and asthmatic subjects

  Population 1 Population 2 p value
  Healthy (n = 7) Asthma (n = 10) Healthy (n = 6) Asthma (n = 6) Healthy (n = 13) Vs Asthma (n = 16)
Female - n (%) 6 (85.7) 6 (60.0) 1 (16.0) 4 (66.6) 1.00
Age - median (±SD) 23 (2.4) 26 (5.9) 20 (0.9) 31 (9.8) 0.02
BMI - median (±SD) 22 (3.9) 25 (9.7) 21 (1.5) 23 (5.0) 0.14
Ethnicity - n (%)      
White 7 (100.0) 2 (20.0) 3 (50.0) 1 (16.6) 0.01
Hispanic 0 3 (30.0) 0 1 (16.6) 0.10
Black 0 3 (30.0) 0 2 (33.3) 0.04
Asian 0 2 (20.0) 3 (50.0) 1 (16.6) 1.00
Other 0 0 0 1 (16.6) 1.00
Atopy - n (%) 1 (14.2) 10 (100) 5 (83.3) 5 (83.3) 0.01
Allergic Rhinitis - n (%) 1 (14.2) 9 (90.0) 2 (33.3) 3 (50.0) 0.01
Chronic Rhinosinusitis - n (%) 1 (14.2) 1 (10.0) 1 (16.6) 2 (33.3) 1.00
Albuterol - n (%) 0 7 (70.0) 0 3 (50.0) 0.004
FEV1 - median (±SD % predicted) 101 (9.6) 85 (10.4) 95 (12.3) 92 (22.2) 0.09
FEV1/FEVC - median (±SD in L) 0.82 (0.04) 0.78 (0.60) 0.85 (0.03) 0.80 (0.03) 0.05
PEF - median (±SD in L/min) 7.06 (1.70) 6.98 (1.50) 7.21 (0.77) 7.47 (1.90) 0.82
  1. Albuterol was the only medication in use within the Asthma group. BMI- body mass index. SD- standard deviation. FEV1 – forced expiratory volume in one second. FVC – forced vital capacity. PEF – Peak expiratory Flow.